485 related articles for article (PubMed ID: 8789658)
21. Atypical and anaplastic meningiomas: prognostic implications of clinicopathological features.
Yang SY; Park CK; Park SH; Kim DG; Chung YS; Jung HW
J Neurol Neurosurg Psychiatry; 2008 May; 79(5):574-80. PubMed ID: 17766430
[TBL] [Abstract][Full Text] [Related]
22. Ki-67 index as a predictive marker of meningioma recurrence following surgical resection.
Mizrachi M; Hartley B; Saleem S; Hintz E; Ziemba Y; Li J; Goenka A; Schulder M
J Clin Neurosci; 2024 Jun; 124():15-19. PubMed ID: 38631196
[TBL] [Abstract][Full Text] [Related]
23. Impact of 1p/19q codeletion on the diagnosis and prognosis of different grades of meningioma.
Basaran R; Uslu S; Gucluer B; Onoz M; Isik N; Tiryaki M; Yakicier C; Sav A; Elmaci I
Br J Neurosurg; 2016 Oct; 30(5):571-6. PubMed ID: 27173440
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical detection of progesterone receptors and the correlation with Ki-67 labeling indices in paraffin-embedded sections of meningiomas.
Nagashima G; Aoyagi M; Wakimoto H; Tamaki M; Ohno K; Hirakawa K
Neurosurgery; 1995 Sep; 37(3):478-82; discussion 483. PubMed ID: 7501113
[TBL] [Abstract][Full Text] [Related]
25. Her2neu amplification associates with Co-deletion 1p/14q in recurrent meningiomas.
Hamilton BO; Sy JS; Megyesi JF; Ang LC
Can J Neurol Sci; 2013 May; 40(3):361-5. PubMed ID: 23603172
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical analysis of p16INK4a, p14ARF, p18INK4c, p21CIP1, p27KIP1 and p73 expression in 271 meningiomas correlation with tumor grade and clinical outcome.
Korshunov A; Shishkina L; Golanov A
Int J Cancer; 2003 May; 104(6):728-34. PubMed ID: 12640680
[TBL] [Abstract][Full Text] [Related]
27. Characterization of intermediate type (WHO "atypical") meningiomas.
Niedermayer I; Kolles H; Zang KD; Feiden W
Clin Neuropathol; 1996; 15(6):330-6. PubMed ID: 8937779
[TBL] [Abstract][Full Text] [Related]
28. [Meningiomas: new prognostic factors].
Sanz Esponera J
An R Acad Nac Med (Madr); 2007; 124(2):319-32; discussion 330-2. PubMed ID: 18069599
[TBL] [Abstract][Full Text] [Related]
29. Meningioma: proliferating potential and clinicoradiological features.
Nakasu S; Nakajima M; Matsumura K; Nakasu Y; Handa J
Neurosurgery; 1995 Dec; 37(6):1049-55. PubMed ID: 8584144
[TBL] [Abstract][Full Text] [Related]
30. Loss of material from chromosome arm 1p during malignant progression of meningioma revealed by fluorescent in situ hybridization.
Ishino S; Hashimoto N; Fushiki S; Date K; Mori T; Fujimoto M; Nakagawa Y; Ueda S; Abe T; Inazawa J
Cancer; 1998 Jul; 83(2):360-6. PubMed ID: 9669820
[TBL] [Abstract][Full Text] [Related]
31. Detection of chromosome 1p deletion using FISH on meningioma touch imprints suggest a region outside chromosome 22 as important in tumor recurrence.
Tamiolakis D; Papadopoulos N; Lambropoulou M; Kotini A; Simopoulos C
Minerva Med; 2003 Feb; 94(1):51-6. PubMed ID: 12719702
[TBL] [Abstract][Full Text] [Related]
32. The application of flow cytometry for evaluating biological aggressiveness of intracranial meningiomas.
Lin YW; Tai SH; Huang YH; Chang CC; Juan WS; Chao LC; Wen MJ; Hung YC; Lee EJ
Cytometry B Clin Cytom; 2015; 88(5):312-9. PubMed ID: 25408130
[TBL] [Abstract][Full Text] [Related]
33. Correlation of DNA content and nucleomorphometric features with World Health Organization grading of meningiomas.
Grunewald JP; Röhl FW; Kirches E; Dietzmann K
Mod Pathol; 1998 Feb; 11(2):216-23. PubMed ID: 9504694
[TBL] [Abstract][Full Text] [Related]
34. DNA topoisomerase II-alpha and cyclin A immunoexpression in meningiomas and its prognostic significance: an analysis of 263 cases.
Korshunov A; Shishkina L; Golanov A
Arch Pathol Lab Med; 2002 Sep; 126(9):1079-86. PubMed ID: 12204057
[TBL] [Abstract][Full Text] [Related]
35. Recurrent and atypical meningiomas--a multiparametric study using Ki67 labelling index, AgNOR and DNA Feulgen staining.
Ferraraccio F; Accardo M; Giangaspero F; Cuccurullo L
Clin Neuropathol; 2003; 22(4):187-92. PubMed ID: 12908755
[TBL] [Abstract][Full Text] [Related]
36. Pediatric meningiomas an aggressive subset: a clinicopathological and immunohistochemical study.
Hui M; Uppin MS; Saradhi MV; Sahu BP; Purohit AK; Sundaram C
J Postgrad Med; 2015; 61(1):32-5. PubMed ID: 25511215
[TBL] [Abstract][Full Text] [Related]
37. Histopathological parameters with Ki-67 and bcl-2 in the prognosis of meningiomas according to WHO 2000 classification.
Uzüm N; Ataoğlu GA
Tumori; 2008; 94(3):389-97. PubMed ID: 18705408
[TBL] [Abstract][Full Text] [Related]
38. Allelic loss at 1p is associated with tumor progression of meningiomas.
Bello MJ; de Campos JM; Kusak ME; Vaquero J; Sarasa JL; Pestaña A; Rey JA
Genes Chromosomes Cancer; 1994 Apr; 9(4):296-8. PubMed ID: 7519053
[TBL] [Abstract][Full Text] [Related]
39. Deletion of chromosome 1p and loss of expression of alkaline phosphatase indicate progression of meningiomas.
Müller P; Henn W; Niedermayer I; Ketter R; Feiden W; Steudel WI; Zang KD; Steilen-Gimbel H
Clin Cancer Res; 1999 Nov; 5(11):3569-77. PubMed ID: 10589773
[TBL] [Abstract][Full Text] [Related]
40. Value of KI-67/MIB-1 labeling index and simpson grading system to predict the recurrence of who grade I intracranial meningiomas compared to who grade II.
Prat-Acín R; Guarín-Corredor MJ; Galeano-Senabre I; Ayuso-Sacido A; Vera-Sempere F
J Clin Neurosci; 2021 Apr; 86():32-37. PubMed ID: 33775343
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
